Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer

NCT00543335 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Lack of Accrual.

Conditions

Lung Cancer

Interventions

DRUG: Sorafenib
PROCEDURE: Radiation Therapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]